TuHURA Biosciences (NASDAQ:HURA) Earns Buy Rating from HC Wainwright
HC Wainwright restated their buy rating on shares of TuHURA Biosciences (NASDAQ:HURA – Free Report) in a research note released on Friday morning,Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for TuHURA Biosciences’ FY2025 earnings at ($0.56) EPS and FY2026 earnings at ($0.52) EPS. TuHURA […]
HC Wainwright restated their buy rating on shares of TuHURA Biosciences (NASDAQ:HURA – Free Report) in a research note released on Friday morning,Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for TuHURA Biosciences’ FY2025 earnings at ($0.56) EPS and FY2026 earnings at ($0.52) EPS. TuHURA […]
